Maia Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Maia Pharmaceuticals, Inc.
Quantité totale PI 19
Rang # Quantité totale PI 80 340
Note d'activité PI 2,4/5.0    27
Rang # Activité PI 28 778
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

12 1
2 0
4 0
0
 
Dernier brevet 2024 - Levothyroxine dispersions
Premier brevet 2018 - Storage stable sincalide formula...
Dernière marque 2022 - MAIA
Première marque 2022 - MAIA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Levothyroxine dispersions. The present invention relates to pharmaceutical dispersions comprising...
Invention Ready-to-use bivalirudin compositions. Ready-to-use liquid bivalirudin compositions, methods of ...
2023 Invention Bortezomib compositions. The present disclosure relates to ready-to-use liquid aqueous bortezomib...
2022 Invention Ready-to-use bivalirudin compositions. Ready-to-use liquid bivalirudin compositions, methods of u...
Invention Bortezomib compositions. The present disclosure relates to ready-to-use liquid aqueous bortezomi...
Invention Dual needle delivery system that connects and deploys needles of a medication delivery device. A ...
Invention Storage stable sincalide formulations. Disclosed herein are solid compositions that comprise sinc...
P/S Pharmaceutical product development services